These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730 [TBL] [Abstract][Full Text] [Related]
3. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. Di Franco MJ; Marlink R; Hunter DJ; Tosteson T; Mayer K; Essex M J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1297-300. PubMed ID: 8254465 [TBL] [Abstract][Full Text] [Related]
4. The effects of methadone on immune function among injecting drug users: a review. McLachlan C; Crofts N; Wodak A; Crowe S Addiction; 1993 Feb; 88(2):257-63. PubMed ID: 8220063 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya. Temmerman M; Nagelkerke N; Bwayo J; Chomba EN; Ndinya-Achola J; Piot P AIDS; 1995 Sep; 9(9):1057-60. PubMed ID: 8527078 [TBL] [Abstract][Full Text] [Related]
6. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City. Siddiqui NS; Brown LS; Phillips RY; Vargas O; Makuch RW AIDS; 1992 Dec; 6(12):1529-33. PubMed ID: 1492936 [TBL] [Abstract][Full Text] [Related]
7. T cell counts from "methadone" and "nonmethadone" groups. Wodak A; Capelhorn J; Crofts N Am J Drug Alcohol Abuse; 1995 May; 21(2):283-4. PubMed ID: 7639213 [No Abstract] [Full Text] [Related]
8. Participation pattern of methadone users and its association with social connection and HIV status: Analyses of electronic health records data. Kwan TH; Wong NS; Lee SS PLoS One; 2019; 14(5):e0216727. PubMed ID: 31071182 [TBL] [Abstract][Full Text] [Related]
9. Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users. Davis RF; Metzger DS; Meyers K; McLellan AT; Mulvaney FD; Navaline HA; Woody GE AIDS; 1995 Jan; 9(1):73-9. PubMed ID: 7893444 [TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Amendola A; Tanzi E; Zappa A; Colzani D; Boschini A; Musher DM; Zanetti AR Vaccine; 2002 Nov; 20(31-32):3720-4. PubMed ID: 12399200 [TBL] [Abstract][Full Text] [Related]
11. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. Mientjes GH; Miedema F; van Ameijden EJ; van den Hoek AA; Schellekens PT; Roos MT; Coutinho RA AIDS; 1991 Jan; 5(1):35-41. PubMed ID: 1829366 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users. Amendola A; Boschini A; Colzani D; Anselmi G; Oltolina A; Zucconi R; Begnini M; Besana S; Tanzi E; Zanetti AR J Med Virol; 2001 Dec; 65(4):644-8. PubMed ID: 11745926 [TBL] [Abstract][Full Text] [Related]
13. A whole blood alternative to traditional methods for CD4+ T lymphocyte determination. Zwerner RK; Hudson JC; Coulter WH; Brunhouse RF; Russell TR J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):31-4. PubMed ID: 8989208 [TBL] [Abstract][Full Text] [Related]
14. Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users. Boccellari AA; Chambers DB; Dilley JW; Shore MD; Tauber MA; Moss AR; Osmond DH J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1040-9. PubMed ID: 7916050 [TBL] [Abstract][Full Text] [Related]
15. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Gourevitch MN; Selwyn PA; Davenny K; Buono D; Schoenbaum EE; Klein RS; Friedland GH Ann Intern Med; 1993 Mar; 118(5):350-5. PubMed ID: 8094280 [TBL] [Abstract][Full Text] [Related]
16. Immune function and drug treatment in anti-retrovirus negative intravenous drug users. Fletcher MA; Klimas NG; Morgan RO Adv Exp Med Biol; 1993; 335():241-6. PubMed ID: 8237601 [No Abstract] [Full Text] [Related]
18. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Selwyn PA; Budner NS; Wasserman WC; Arno PS Public Health Rep; 1993; 108(4):492-500. PubMed ID: 8393579 [TBL] [Abstract][Full Text] [Related]
19. Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection. Quang-Cantagrel ND; Wallace MS; Ashar N; Mathews C Eur J Pain; 2001; 5(4):415-20. PubMed ID: 11743707 [TBL] [Abstract][Full Text] [Related]
20. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. Lamster IB; Begg MD; Mitchell-Lewis D; Fine JB; Grbic JT; Todak GG; el-Sadr W; Gorman JM; Zambon JJ; Phelan JA Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):163-74. PubMed ID: 7936584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]